Eigr investor relations
WebApr 10, 2024 · A high-level overview of Eiger BioPharmaceuticals, Inc. (EIGR) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and … Web19 hours ago · Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on the development of therapies for hepatitis delta virus (HDV) and other serious diseases, appointed William Kachioff as chief financial officer and James Vollins general counsel, chief compliance officer and corporate secretary. Kachioff is …
Eigr investor relations
Did you know?
WebNov 8, 2024 · NEW YORK, NY / ACCESSWIRE / November 8, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers ofEiger BioPharmaceuticals, Inc. ("Eiger" or the "Company") (NASDAQ:EIGR). Investors who purchased Eiger sharesare encouraged to obtain additional information and assist the … WebMay 5, 2024 · The Company reported a net loss of $22.6 million, or $0.64 per share for first quarter 2024. This compares to net income of $29.2 million, or $0.85 on a fully diluted per share basis for the same ...
WebApr 13, 2024 · Mr. Kachioff is highly experienced in corporate finance, investor relations, capital formation, corporate governance and manufacturing accounting and systems. He has over 30 years of life sciences industry experience and is currently a consulting CFO with Danforth Advisors , with whom Eiger has contracted for his services. WebApr 13, 2024 · PALO ALTO, Calif., April 13, 2024 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical …
Web1 day ago · Eiger BioPharmaceuticals, Inc. Apr 13, 2024, 08:00 ET. William G. Kachioff appointed as Chief Financial Officer. James A. Vollins appointed as General Counsel, Chief Compliance Officer and ... WebMar 8, 2024 · We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold …
WebEiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Long Term Investor Alert: Investigation of Potential Wrongdoing San Diego, CA -- (SBWIRE) -- 01/20/2024 -- An investigation was announced long-term investors in shares of Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) concerning potential breaches of fiduciary duties by certain directors of …
WebEiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies for hepatitis delta virus … glory qfr010WebFINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in Eiger BioPharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm PR Newswire … glory putlockerWebNov 16, 2024 · Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Notifies Eiger BioPharmaceuticals, Inc. (EIGR) Investors of Class Action and Encourages Investors to Actively Participate November 16, 2024 ... glory quickchangeWebApr 10, 2024 · Financial Performance. In 2024, EIGR's revenue was $13.48 million, an increase of 11.05% compared to the previous year's $12.14 million. Losses were -$96.78 million, 185.3% more than in 2024. Financial Statements. bohr model for waterWebApr 11, 2024 · The Eiger BioPharmaceuticals, Inc. stock price fell by -11.87% on the last day (Tuesday, 28th Mar 2024) from $1.01 to $0.89. During the last trading day the stock fluctuated 16.09% from a day low at $0.87 to a day high of $1.01. The price has fallen in 6 of the last 10 days and is down by -23.92% for this period. bohr model for an oxygen anionWebFeb 8, 2024 · Earnings announcement* for EIGR: Mar 9, 2024. Eiger BioPharmaceuticals, Inc. is estimated to report earnings on 03/09/2024. The upcoming earnings date is derived from an algorithm based on a ... glory purple adidas socksWebApr 10, 2024 · A high-level overview of Eiger BioPharmaceuticals, Inc. (EIGR) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. bohr model for the neon